Thrombolex, Inc., a commercial-stage developer of a differentiated pharmacomechanical lysis platform for the treatment of ...

Pulmonary arterial hypertension, or PAH, is a rare and severe disease characterized by elevated blood pressure in the ...

Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of ...

Therapeutic progress in lung squamous cell carcinoma has lagged, with recent antiangiogenic–checkpoint inhibitor combinations ...

Doctors in Greater Noida performed North India’s first PAND procedure to treat a young woman with long-standing PAH, improving symptoms and offering a minimally invasive option beyond medication.

Asthma and chronic obstructive pulmonary disease patients will receive better care closer to home under a landmark £10million partnership Care for ...

BioCardia, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases ...

Reinventing pulmonary care medically improves early diagnosis and interdisciplinary management for complex patients with COPD ...

Nearly one million Israelis live with chronic lung diseases such as asthma and COPD, and for them the current security ...

A ukulele and singing group at a hospice has been described as a "lifeline" by patients. The 18-week music therapy programme ...

For years, researchers have suspected that a hormone called relaxin could be an effective treatment for certain ...

Hunt Regional Healthcare recently announced the purchase of Pulmonary Associates of Greenville, calling it an effort to ...